Crossmark

A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma

Crossref DOI link: https://doi.org/10.1038/s41598-025-85537-7

Published Online: 2025-01-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liao, Ru-Gen

Wang, Jin-Hong

Zhang, Fan

Fang, Yu-Tong

Zhou, Li

Zhang, Yong-Qu
License Information

Text and Data Mining valid from 2025-01-09

Version of Record valid from 2025-01-09
More Information

Article History

Received: 27 August 2024

Accepted: 3 January 2025

First Online: 9 January 2025

Declarations

:

: The authors declare no competing interests.

: Ethical approval for this study was granted by the Ethics Review Committee of the Cancer Hospital of Shantou University Medical College.

Document is current

Any future updates will be listed below